Clifford Chance advises Royal DSM on the agreement to sell its Engineering Materials business for an enterprise value of EUR 3.85 billion

1 June 2022

Gregory Crookes , Hansuya Reddy , Pieter Leefers , Sabine van den Heuvel , Liesbeth Buiter , Johanneke Butijn , Ernst van der Touw , Andrea Karkotis , Richard Nowak , Folko de Vries , Michiel Sunderman , Pascal Borsjé , Jurre Jurriëns , Jaap Tempelman , Andrei Mikes , Tamlin Higgins , Orsolya Gondos , Floris van de Bult , Wijnanda Rutten , Stefan Simon , Torsten Syrbe , Yuki Nakatori , Gert Cuppens , Maxime Nyamabu , Paul Koppel , David Walsh , Julius Pak , Timothy Cornell
Amsterdam , Brussels , Düsseldorf , Frankfurt , New York , Shanghai , Tokyo , Washington D.C.

Clifford Chance advises Royal DSM on the agreement to sell its Engineering Materials business for an enterprise value of EUR 3.85 billion

International law firm Clifford Chance has advised its long-standing client Royal DSM, a global purpose-led science-based company, on the agreement to sell its Engineering Materials business to Advent International and LANXESS for an enterprise value of EUR 3.85 billion.

The proposed transaction marks the conclusion of DSM’s review of strategic options for its two Materials businesses and, following the agreement to sell DSM Protective Materials to Avient Corporation in April, the transformation of DSM into a focused science-based leader in Health, Nutrition & Bioscience.

DSM Engineering Materials will become part of a newly created joint venture, together with LANXESS’s High Performance Materials business, which will be co-owned by Advent International (60%) and LANXESS (40%). Completion of the transaction, which is subject to the customary conditions and approvals, is expected in H1, 2023. Read more about the transaction here.

The Clifford Chance cross-border team was led out of Amsterdam by Gregory Crookes and the core team consisted of Hansuya Reddy, Pieter Leefers, Sabine van den Heuvel, Helen Liefting, Shaun Campbell and Sarah van Eijk. The wider team consisted of Liesbeth Buiter, Joris Dortmans, Johanneke Butijn, Merel Vermolen, Stephanie Phillips, Ernst van der Touw, Julius des Tombe, Julia van Heusden, Andrea Karkotis, Richard Nowak (Corporate), Folko de Vries (Finance), Michiel Sunderman, Pascal Borsjé, Alec Sanderson (Tax), Frans Muller, Jurre Jurriëns, Bruno Weisser-Lopez (Antitrust and FDI), Jaap Tempelman, Andrei Mikes, Sophie Wijdeveld, Tamlin Higgins, Orsolya Gondos (Tech, IP and contracts), Floris van de Bult, Wijnanda Rutten, IJsbrand de Jong, Iga Mamczarz, Arie Torres (Employment, pensions and benefits) and Esmée Oldenkamp (Notarial) in Amsterdam, Stefan Simon in Frankfurt, Torsten Syrbe in Düsseldorf, Peter Zhao, Mercia Wang and Yvonne Cheng in Shanghai, Yuki Nakatori in Tokyo, Gert Cuppens and Maxime Nyamabu in Brussels, Paul Koppel, Jason A. Sacks and David Walsh in New York and Timothy Cornell, Julius Pak and Sabine Kobienia in Washington.